Search

Your search keyword '"Valerates pharmacology"' showing total 543 results

Search Constraints

Start Over You searched for: Descriptor "Valerates pharmacology" Remove constraint Descriptor: "Valerates pharmacology"
543 results on '"Valerates pharmacology"'

Search Results

201. Identification of a cysteine residue in the active site of nitroalkane oxidase by modification with N-ethylmaleimide.

202. Effects of beta-hydroxy-beta-methylbutyrate on muscle damage after a prolonged run.

203. Beta-hydroxy-beta-methylbutyrate (HMB) supplementation and the promotion of muscle growth and strength.

204. beta-hydroxy-beta-methylbutyrate (HMB) supplementation in humans is safe and may decrease cardiovascular risk factors.

205. Net portal appearance of volatile fatty acids in sheep intraruminally infused with mixtures of acetate, propionate, isobutyrate, butyrate, and valerate.

206. Excess of glucocorticoids impairs whole-body antioxidant status in young rats. relation to the effect of dexamethasone in soleus muscle and spleen.

207. Conformationally constrained analogues of diacylglycerol (DAG). 16. How much structural complexity is necessary for recognition and high binding affinity to protein kinase C?

208. Mechanism of nitroalkane oxidase: 2. pH and kinetic isotope effects.

209. DNA damage by 5-aminolevulinic and 4,5-dioxovaleric acids in the presence of ferritin.

210. Effects of reactive oxygen species on brain synaptic plasma membrane Ca(2+)-ATPase.

211. Role of epidermal growth factor receptor in basal and stimulated colonic epithelial cell migration in vitro.

212. Enhancement of cellular and humoral immunity in young broilers by the dietary supplementation of beta-hydroxy-beta-methylbutyrate.

213. New supplement treats AIDS wasting successfully.

214. Dietary supplements and the promotion of muscle growth with resistance exercise.

215. In vitro exposure with beta-hydroxy-beta-methylbutyrate enhances chicken macrophage growth and function.

216. Association between ligand-induced conformational changes of integrin IIbbeta3 and IIbbeta3-mediated intracellular Ca2+ signaling.

217. DNA alkylation by 4,5-dioxovaleric acid, the final oxidation product of 5-aminolevulinic acid.

218. In vitro effects of an azo compound on the haemolysis and unsaturated fatty acids of red blood cells.

219. The use of synthetic analogues of Arg-Gly-Asp (RGD) and soluble receptor of tumor necrosis factor to prevent acute and chronic experimental liver injury.

220. The effect of a high dose of 3-hydroxy-3-methylbutyrate on protein metabolism in growing lambs.

221. Analysis of Arg-Gly-Asp mimetics and soluble receptor of tumour necrosis factor as therapeutic modalities for concanavalin A induced hepatitis in mice.

222. Effect of leucine metabolite beta-hydroxy-beta-methylbutyrate on muscle metabolism during resistance-exercise training.

223. Infusion of various short chain fatty acids causes different changes in the blood glucose and insulin concentrations in growing lambs deprived of food overnight.

224. Age does not affect uterine resistance to vascular flow in patients undergoing oocyte donation.

225. Inhibition of experimentally-induced liver cirrhosis in rats by a nonpeptidic mimetic of the extracellular matrix-associated Arg-Gly-Asp epitope.

226. Calcium beta-hydroxy-beta-methylbutyrate. 1. Potential role as a phosphate binder in uremia: in vitro study.

227. Age and the effects of 2-D,L-amino-5-phosphonovalerate in an area of the chick forebrain which is essential for early learning.

228. Inactivation of pathogens during aerobic and anaerobic treatments at low temperatures.

229. Treatment of immune cell-mediated liver damage by nonpeptidic mimetics of the extracellular matrix-associated Arg-Gly-Asp epitope.

230. Monoamine release in the rat striatum is induced by delta-guanidinovaleric acid and inhibited by GABA agonists.

231. Colostral milk fat percentage and pig performance are enhanced by feeding the leucine metabolite beta-hydroxy-beta-methyl butyrate to sows.

232. Oxidation of human red blood cells by a free radical initiator and effects of radical scavengers.

233. Effects of beta-hydroxy-beta-methyl butyrate on performance and carcass quality of feedlot steers.

234. Peroxisome proliferation of hepatocytes in rats by a microbial degradation product of cholic acid, 4-(decahydro-6-methyl-3-oxocyclopenta(f)quinoline-7-yl)valeric acid.

235. Synthesis of methyl 3-(2-octadecylcyclopropen-1-yl)propanoate and methyl 3-(2-octadecylcyclopropen-1-yl)pentanoate and cyclopropane fatty acids as possible inhibitors of mycolic acid biosynthesis.

236. Nonpeptidic analogues of the Arg-Gly-Asp (RGD) sequence specifically inhibit the adhesion of human tenon's capsule fibroblasts to fibronectin.

237. Inhibition of metastatic cell colonization in murine lungs and tumor-induced morbidity by non-peptidic Arg-Gly-Asp mimetics.

238. Activation of a peroxisome-proliferating catabolite of cholic acid to its CoA ester.

239. Induction of peroxisomal beta-oxidation by a microbial catabolite of cholic acid in rat liver and cultured rat hepatocytes.

240. Effects of isoacids, urea, and sulfur on ruminal fermentation in sheep fed high fiber diets.

241. Hydrophobic anion activation of human liver chi chi alcohol dehydrogenase.

242. Excitatory and inhibitory amino-acidergic determinants of the pressure-induced neuronal hyperexcitability in rat hippocampal slices.

243. R68070, a combined thromboxane/endoperoxide receptor antagonist and thromboxane synthase inhibitor, inhibits human platelet activation in vitro and in vivo: a comparison with aspirin.

244. Increased skin flap viability after treatment with forskolin or with ridogrel, a thromboxane synthesis inhibitor and receptor blocker.

245. Effects of intravenous injection of butyrate, valerate and their isomers on endocrine pancreatic responses in conscious sheep (Ovis aries).

246. Oudemansin, strobilurin A, strobilurin B and myxothiazol: new inhibitors of the bc1 segment of the respiratory chain with an E-beta-methoxyacrylate system as common structural element.

247. Hypolipidaemic action of gemfibrozil in adult nephrotics.

248. In vivo inactivation of gamma-aminobutyric acid-alpha-ketoglutarate transaminase by 4-amino-5-fluoropentanoic acid.

249. Comparison of GR32191, R68070 and CV-4151 upon U-46619- and collagen-induced platelet aggregation in vitro and ex vivo.

250. Kinetics of erythrocyte penetration by aliphatic acids.

Catalog

Books, media, physical & digital resources